# Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer

> **NCT03448458** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 17 (actual)

## Conditions studied

- Castration-Resistant Prostate Carcinoma
- Metastatic Prostate Carcinoma
- Stage IV Prostate Cancer AJCC v7

## Interventions

- **PROCEDURE:** CT (Computed Tomography)
- **DRUG:** Gallium Ga 68-DOTATATE
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT03448458
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-22
- **Primary completion:** 2023-02-06
- **Final completion:** 2023-02-06
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03448458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03448458, "Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03448458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*